{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:18:23Z","timestamp":1791001103094,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014820","name":"Li Ka Shing Faculty of Medicine, University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014820","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022411","name":"University of Hong Kong-Shenzhen Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008476","name":"University of California, Irvine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008476","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.radonc.2024.110529","type":"journal-article","created":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T10:06:10Z","timestamp":1725789970000},"page":"110529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Brachial plexopathy following stereotactic body radiation therapy in apical lung malignancies: A dosimetric pooled analysis of individual patient data"],"prefix":"10.1016","volume":"200","author":[{"given":"Hui","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8513-8128","authenticated-orcid":false,"given":"Yi-Han","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas G","family":"Zaorsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng-Min","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Tong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Long","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Bin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.radonc.2024.110529_b0005","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.radonc.2024.110529_b0010","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1200\/JCO.21.01611","article-title":"Inoperable early-stage non-small-cell lung cancer: stereotactic ablative radiotherapy and rationale for systemic therapy","volume":"40","author":"Daly","year":"2022","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.radonc.2024.110529_b0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1200\/JCO.21.01719","article-title":"Practical management of oligometastatic non-small-cell lung cancer","volume":"40","author":"Jasper","year":"2022","journal-title":"J Clin Oncol"},{"issue":"10405","key":"10.1016\/j.radonc.2024.110529_b0020","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(23)01384-3","article-title":"Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial","volume":"402","author":"Chang","year":"2023","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/j.radonc.2024.110529_b0025","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.jtcvs.2023.08.023","article-title":"Superior sulcus non-small cell lung cancers (Pancoast tumors): Current outcomes after multidisciplinary management","volume":"166","author":"McLaughlin","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.radonc.2024.110529_b0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/JTO.0b013e3181914d52","article-title":"Survival after trimodality treatment for superior sulcus and central T4 non-small cell lung cancer","volume":"4","author":"De Leyn","year":"2009","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1016\/j.radonc.2024.110529_b0035","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijrobp.2022.05.004","article-title":"Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes","volume":"114","author":"Harrow","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110529_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109804","article-title":"Impact of radiation dose to the immune system on disease progression and survival for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy","volume":"186","author":"Wang","year":"2023","journal-title":"Radiother Oncol: J Eur Soc Therapeutic Radiol Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2024.110529_b0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jtho.2019.08.2505","article-title":"Biologically effective dose in stereotactic body radiotherapy and survival for patients with early-stage NSCLC","volume":"15","author":"Moreno","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2024.110529_b0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2021.04.010","article-title":"Higher biologically effective dose is associated with improved survival in patients with squamous cell carcinoma of the lung treated with stereotactic body radiation therapy","volume":"160","author":"Parzen","year":"2021","journal-title":"Radiother Oncol: J Eur Soc Therapeutic Radiol Oncol"},{"issue":"8","key":"10.1016\/j.radonc.2024.110529_b0055","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1080\/0284186X.2019.1601255","article-title":"Radiation-induced brachial plexus toxicity after SBRT of apically located lung lesions","volume":"58","author":"Lindberg","year":"2019","journal-title":"Acta oncologica (Stockholm, Sweden)"},{"issue":"3","key":"10.1016\/j.radonc.2024.110529_b0060","first-page":"189","article-title":"Investigation of brachial plexus dose that exceeds RTOG constraints for apical lung tumors treated with four- or five-fraction stereotactic body radiation therapy","volume":"6","author":"Manyam","year":"2019","journal-title":"J Radiosurg SBRT"},{"issue":"3","key":"10.1016\/j.radonc.2024.110529_b0065","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/j.prro.2021.12.002","article-title":"Stereotactic body radiation therapy for apical lung tumors: dosimetric analysis of the brachial plexus and preliminary clinical outcomes","volume":"12","author":"Morse","year":"2022","journal-title":"Pract Radiat Oncol"},{"issue":"3","key":"10.1016\/j.radonc.2024.110529_b0070","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/j.prro.2022.12.002","article-title":"Brachial plexopathy after single-fraction stereotactic body radiation therapy in apical lung tumors","volume":"13","author":"Iovoli","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110529_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109583","article-title":"Radiation-induced inferior brachial plexopathy after stereotactic body radiotherapy: Pooled analyses of risks","volume":"182","author":"Milano","year":"2023","journal-title":"Radiother Oncol: J Eur Soc Therapeutic Radiol Oncol"},{"issue":"4","key":"10.1016\/j.radonc.2024.110529_b0080","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ijrobp.2022.11.012","article-title":"Hypofractionated stereotactic radiation therapy dosimetric tolerances for the inferior aspect of the brachial plexus: a systematic review","volume":"118","author":"Milano","year":"2024","journal-title":"Int J Radiat Oncol, Biol, Phys"},{"issue":"1","key":"10.1016\/j.radonc.2024.110529_b0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.adro.2017.10.002","article-title":"Brachial plexopathy after stereotactic body radiation therapy for apical lung cancer: Dosimetric analysis and preliminary clinical outcomes","volume":"3","author":"Sood","year":"2018","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"10.1016\/j.radonc.2024.110529_b0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijrobp.2015.01.016","article-title":"Radiation therapy to the plexus brachialis in breast cancer patients: analysis of paresthesia in relation to dose and volume","volume":"92","author":"Lundstedt","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.radonc.2024.110529_b0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.radonc.2004.03.005","article-title":"Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients?","volume":"71","author":"Bajrovic","year":"2004","journal-title":"Radiother Oncol: J Eur Soc Therapeutic Radiol Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2024.110529_b0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0360-3016(93)90171-Q","article-title":"Radiation-induced brachial plexopathy: neurological follow-up in 161 recurrence-free breast cancer patients","volume":"26","author":"Olsen","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.radonc.2024.110529_b0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijrobp.2011.11.019","article-title":"Brachial plexus-associated neuropathy after high-dose radiation therapy for head-and-neck cancer","volume":"84","author":"Chen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.radonc.2024.110529_b0110","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ijrobp.2013.11.244","article-title":"Dose\u2013volume modeling of brachial plexus-associated neuropathy after radiation therapy for head-and-neck cancer: findings from a prospective screening protocol","volume":"88","author":"Chen","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.radonc.2024.110529_b0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.radonc.2024.110529_b0120","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0167-8140(90)90057-4","article-title":"Radiation-induced brachial plexus injury: follow-up of two different fractionation schedules","volume":"18","author":"Powell","year":"1990","journal-title":"Radiother Oncol: J Eur Soc Therapeutic Radiol Oncol"},{"issue":"4","key":"10.1016\/j.radonc.2024.110529_b0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.semradonc.2008.04.001","article-title":"An overview of hypofractionation and introduction to this issue of seminars in radiation oncology","volume":"18","author":"Timmerman","year":"2008","journal-title":"Semin Radiat Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2024.110529_b0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijrobp.2021.09.027","article-title":"A Story of hypofractionation and the table on the wall","volume":"112","author":"Timmerman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.radonc.2024.110529_b0135","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ijrobp.2018.11.051","article-title":"Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): a randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage i peripheral non-small cell lung cancer","volume":"103","author":"Videtic","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.radonc.2024.110529_b0140","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jamaoncol.2018.1251","article-title":"Stereotactic Body radiation therapy for operable early-stage lung cancer: findings from the nrg oncology RTOG 0618 trial","volume":"4","author":"Timmerman","year":"2018","journal-title":"JAMA Oncol"},{"issue":"15","key":"10.1016\/j.radonc.2024.110529_b0145","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG Oncology\/RTOG 0813 Trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.radonc.2024.110529_b0150","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2024.110529_b0155","doi-asserted-by":"crossref","unstructured":"Diez P, Hanna GG, Aitken KL, et al. UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy. Clinical oncology (Royal College of Radiologists (Great Britain)). 2022; 34 (5): 288-300.","DOI":"10.1016\/j.clon.2022.02.010"},{"issue":"1","key":"10.1016\/j.radonc.2024.110529_b0160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clon.2017.09.007","article-title":"UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy","volume":"30","author":"Hanna","year":"2018","journal-title":"Clin Oncol"},{"issue":"5","key":"10.1016\/j.radonc.2024.110529_b0165","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.ijrobp.2008.03.004","article-title":"Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer","volume":"72","author":"Hall","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.radonc.2024.110529_b0170","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ijrobp.2010.07.1977","article-title":"Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus","volume":"81","author":"Kong","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"32","key":"10.1016\/j.radonc.2024.110529_b0175","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1200\/JCO.2015.61.9569","article-title":"Cost-effectiveness analysis of regorafenib for metastatic colorectal cancer","volume":"33","author":"Goldstein","year":"2015","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.radonc.2024.110529_b0180","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jamaoncol.2017.4211","article-title":"Estimating cost-effectiveness of a multimodal ovarian cancer screening program in the united states: secondary analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)","volume":"4","author":"Moss","year":"2018","journal-title":"JAMA Oncol"},{"issue":"12","key":"10.1016\/j.radonc.2024.110529_b0185","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1001\/jamadermatol.2019.2941","article-title":"Decision-analytic modeling for time-effectiveness of the sequence of induction treatments for moderate to severe plaque psoriasis","volume":"155","author":"Zidane","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.radonc.2024.110529_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110023","article-title":"Dosimetric analysis of brachial plexopathy after stereotactic body radiotherapy: Significance of organ delineation","volume":"190","author":"Niu","year":"2024","journal-title":"Radiothe Oncol: J Eur Soc Therapeutic Radiol Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2024.110529_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2020.10.039","article-title":"High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): An Overview","volume":"110","author":"Grimm","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.radonc.2024.110529_b0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2020.11.020","article-title":"A primer on dose-response data modeling in radiation therapy","volume":"110","author":"Moiseenko","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.radonc.2024.110529_b0205","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamaoncol.2018.1258","article-title":"Long-term results of stereotactic body radiation therapy in medically inoperable stage i non-small cell lung cancer","volume":"4","author":"Timmerman","year":"2018","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.radonc.2024.110529_b0210","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1470-2045(18)30896-9","article-title":"Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial","volume":"20","author":"Ball","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110529_b0215","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events Version4.0.(https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_50)."},{"key":"10.1016\/j.radonc.2024.110529_b0220","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events Version5.0.(https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_50)."},{"issue":"1","key":"10.1016\/j.radonc.2024.110529_b0225","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijrobp.2019.09.038","article-title":"Spinal cord dose tolerance to stereotactic body radiation therapy","volume":"110","author":"Sahgal","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.radonc.2024.110529_b0230","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/S0360-3016(00)00500-9","article-title":"Comments on the use of the Lyman-Kutcher-Burman model to describe tissue response to nonuniform irradiation","volume":"47","author":"Deasy","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3 Suppl","key":"10.1016\/j.radonc.2024.110529_b0235","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1016\/j.ijrobp.2009.06.094","article-title":"Improving normal tissue complication probability models: the need to adopt a \u201cdata-pooling\u201d culture","volume":"76","author":"Deasy","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.radonc.2024.110529_b0240","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13014-021-01822-5","article-title":"Estimating the tolerance of brachial plexus to hypofractionated stereotactic body radiotherapy: a modelling-based approach from clinical experience","volume":"16","author":"Kapitanova","year":"2021","journal-title":"Radiation oncology (London, England)"},{"issue":"3","key":"10.1016\/j.radonc.2024.110529_b0245","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.radonc.2009.04.018","article-title":"Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites","volume":"93","author":"Forquer","year":"2009","journal-title":"Radiother Oncol: J Eur Soc Therapeutic Radiol Oncol"},{"issue":"2","key":"10.1016\/j.radonc.2024.110529_b0250","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijrobp.2021.09.029","article-title":"Brachial plexus tolerance to single-session SABR in a pig model","volume":"112","author":"Hrycushko","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110529_b0255","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejmp.2017.06.006","article-title":"IGRT and motion management during lung SBRT delivery","volume":"44","author":"Caillet","year":"2017","journal-title":"Phys Med"},{"key":"10.1016\/j.radonc.2024.110529_b0260","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejmp.2016.11.114","article-title":"What do radiation oncologists require for future advancements in lung SBRT?","volume":"44","author":"Ricardi","year":"2017","journal-title":"Phys Med"},{"issue":"11","key":"10.1016\/j.radonc.2024.110529_b0265","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"J Am Med Assoc"},{"issue":"20","key":"10.1016\/j.radonc.2024.110529_b0270","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1088\/0031-9155\/49\/20\/012","article-title":"Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy","volume":"49","author":"Guerrero","year":"2004","journal-title":"Phys Med Biol"},{"issue":"10","key":"10.1016\/j.radonc.2024.110529_b0275","doi-asserted-by":"crossref","first-page":"L9","DOI":"10.1088\/0031-9155\/50\/10\/L01","article-title":"The modified linear-quadratic model of Guerrero and Li can be derived from a mechanistic basis and exhibits linear-quadratic-linear behaviour","volume":"50","author":"Carlone","year":"2005","journal-title":"Phys Med Biol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024035072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024035072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:40:57Z","timestamp":1762256457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024035072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":55,"alternative-id":["S0167814024035072"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110529","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brachial plexopathy following stereotactic body radiation therapy in apical lung malignancies: A dosimetric pooled analysis of individual patient data","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110529"}}